Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences

Am J Infect Control. 2011 Oct;39(8):640-646. doi: 10.1016/j.ajic.2010.11.005. Epub 2011 Jun 8.

Abstract

Background: Central venous lines (CVLs) are used extensively in intensive care units (ICUs) but can sometimes lead to catheter-related blood stream infections (CRBSIs). This study evaluated a "CVL bundle" to see whether the CRBSI rate would decrease, analyze any changes in the flora of CRBSIs, and project any decrease in health care costs.

Methods: The CVL bundle was implemented on all patients admitted to the ICU starting January 2008. Data from CRBSI rates from 2006 and 2007 were pooled to compare the intervention. A Poisson analysis generated a relative risk reduction. Determination of costs were made by taking the excess length of stay multiplied by other costs (supplies, medications, cost of replacement of CVL) at our institution.

Results: Overall infection rates decreased with an improvement in CRBSIs in all ICUs that participated. Although the proportion of gram-negative organisms did not change significantly, there was a decrease in the proportion of gram-positive infections (P = .05) and an increase in fungal infections (P = .04). The total excess cost per organism was determined by the following: total excess cost = excess length of stay + replacement of CVL + drug administration + antibiotic cost. The weighted excess cost took the total excess cost times a correction factor based on organism frequency. The total excess cost of any given CRBSI is approximately $32,254.

Conclusion: Preventing CRBSIs can improve patient care while reducing hospital stays, costs, and possible mortality. CVL bundles are fairly easy to perform with reproducible results.

Publication types

  • Evaluation Study

MeSH terms

  • Bacteremia / economics*
  • Bacteremia / epidemiology*
  • Bacteremia / microbiology
  • Bacteremia / prevention & control
  • Catheter-Related Infections / economics*
  • Catheter-Related Infections / epidemiology*
  • Catheter-Related Infections / microbiology
  • Catheter-Related Infections / prevention & control
  • Catheterization, Central Venous / adverse effects
  • Catheterization, Central Venous / economics
  • Catheterization, Central Venous / instrumentation*
  • Cost-Benefit Analysis
  • Cross Infection / epidemiology
  • Cross Infection / prevention & control
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Positive Bacteria / isolation & purification
  • Health Care Costs
  • Humans
  • Infection Control / methods
  • Intensive Care Units / economics
  • Length of Stay
  • Program Evaluation*